Michael W Cho

Summary

Affiliation: Case Western Reserve University
Country: USA

Publications

  1. ncbi Subunit protein vaccines: theoretical and practical considerations for HIV-1
    Michael W Cho
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    Curr Mol Med 3:243-63. 2003
  2. ncbi Structural characterization of HIV gp41 with the membrane-proximal external region
    Wuxian Shi
    Center for Synchrotron Biosciences, Case Western Reserve University, Cleveland, OH 44106, USA
    J Biol Chem 285:24290-8. 2010
  3. ncbi Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry
    Dong P Han
    Case Western Reserve University School of Medicine, Department of Medicine, Division of Infectious Diseases, 10900 Euclid Avenue, Cleveland, OH 44106 4984, USA
    J Virol 81:12029-39. 2007
  4. ncbi Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
    Dong P Han
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 350:15-25. 2006
  5. ncbi Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry
    Liwen Wang
    Center for Proteomics and Bioinformatics, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Biochemistry 49:9032-45. 2010
  6. ncbi Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
    Adam Penn-Nicholson
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 372:442-56. 2008
  7. ncbi Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
    Dong P Han
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 326:140-9. 2004
  8. ncbi Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies
    Young B Kim
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    Virology 305:124-37. 2003
  9. ncbi Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells
    Gaia Vasiliver-Shamis
    VA Medical Center, 423 E 23rd St, Room 18 124 North, New York, NY 10010, USA
    J Virol 82:9445-57. 2008
  10. ncbi Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice
    Jong-Soo Lee
    BioLeaders corporation, Daejeon, Korea
    J Virol 80:4079-87. 2006

Research Grants

Collaborators

  • Wuxian Shi
  • Keiji Takamoto
  • D C Montefiori
  • M L Dustin
  • Dong P Han
  • Young B Kim
  • Adam Penn-Nicholson
  • Liwen Wang
  • Gaia Vasiliver-Shamis
  • Rais Ansari
  • Jong-Soo Lee
  • Ronald L Willey
  • Yali Qin
  • Serguei Ilchenko
  • Jen Bohon
  • Mark R Chance
  • Hualin Li
  • Jianping Liu
  • Catarina E Hioe
  • Toby Starr
  • Hanna Park
  • Gurvinder Kaur
  • Russell Thomson
  • Maria Luisa Visciano
  • Thomas O Cameron
  • Soon J Kim
  • Michael Tuen
  • Rajnish Kumar
  • Teresa W Wu
  • Motashim Lohani
  • Kwang Kim
  • Seung-Pyo Hong
  • Haryoung Poo
  • Chul-Joong Kim
  • Moon-Hee Sung
  • Eun Kim
  • Hyung G Kim
  • Leo L M Poon
  • Russ Byrum
  • Larry O Arthur
  • Jeffrey L Rossio Jr
  • Malcolm A Martin
  • Jeffrey D Lifson
  • Tatsuhiko Igarashi
  • Julian Bess Jr
  • Carlos Cao
  • Yasuyuki Endo
  • Michael Piatak

Detail Information

Publications11

  1. ncbi Subunit protein vaccines: theoretical and practical considerations for HIV-1
    Michael W Cho
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    Curr Mol Med 3:243-63. 2003
    ..Finally, some of the factors that must be considered in designing and evaluating future vaccine candidates will be discussed...
  2. ncbi Structural characterization of HIV gp41 with the membrane-proximal external region
    Wuxian Shi
    Center for Synchrotron Biosciences, Case Western Reserve University, Cleveland, OH 44106, USA
    J Biol Chem 285:24290-8. 2010
    ....
  3. ncbi Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry
    Dong P Han
    Case Western Reserve University School of Medicine, Department of Medicine, Division of Infectious Diseases, 10900 Euclid Avenue, Cleveland, OH 44106 4984, USA
    J Virol 81:12029-39. 2007
    ..Amino acid sequence analyses of S proteins encoded by viruses isolated from animals and humans suggest that glycosylation sites N227 and N699 have facilitated zoonotic transmission...
  4. ncbi Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
    Dong P Han
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 350:15-25. 2006
    ..a. 22-44 and 351-357) artificially linked together by glycine, exhibited a potent antiviral activity with IC50 of about 0.1 microM. This novel peptide is a promising candidate as a therapeutic agent against this deadly emerging pathogen...
  5. ncbi Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry
    Liwen Wang
    Center for Proteomics and Bioinformatics, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Biochemistry 49:9032-45. 2010
    ..In addition, the data illustrate interactions between specific sugar moieties and amino acid side chains potentially important to the gp120-OD8 structure...
  6. ncbi Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
    Adam Penn-Nicholson
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 372:442-56. 2008
    ..These soluble gp41 fusion proteins could be an important source of antigens for future vaccine development efforts...
  7. ncbi Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
    Dong P Han
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Virology 326:140-9. 2004
    ..The high-throughput capacity of this procedure and the safety of using SARS pseudoviruses should make possible large-scale analyses of neutralizing antibody responses against SARS-CoV...
  8. ncbi Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies
    Young B Kim
    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    Virology 305:124-37. 2003
    ..However, the observation that the immune responses could be redirected by altering the protein composition might allow us to explore alternative strategies for modifying the antigenic properties of HIV-1 envelope glycoprotein...
  9. ncbi Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells
    Gaia Vasiliver-Shamis
    VA Medical Center, 423 E 23rd St, Room 18 124 North, New York, NY 10010, USA
    J Virol 82:9445-57. 2008
    ..The virological synapse was formed transiently, with the initiation of migration within 30 min. Thus, HIV-1 gp120-presenting surfaces induce a transient stop signal and supramolecular segregation in noninfected CD4(+) T cells...
  10. ncbi Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice
    Jong-Soo Lee
    BioLeaders corporation, Daejeon, Korea
    J Virol 80:4079-87. 2006
    ..These results indicate that mucosal immunization with recombinant L. casei expressing SARS-associated coronavirus S protein on its surface provides an effective means for eliciting protective immune response against the virus...
  11. ncbi Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
    Ronald L Willey
    Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Virol 77:1163-74. 2003
    ..These results indicate that despite the protection from SHIV-induced disease, the vaccinated animals still harbored replication-competent and pathogenic virus...

Research Grants7

  1. Development of a Safer Smallpox Vaccine
    Michael Cho; Fiscal Year: 2003
    ..A successful completion of the proposed projects would allow better understanding of immune correlates of protection against vaccinia virus and could facilitate development of a safer smallpox vaccine. ..
  2. Developing HIV-1 Vaccine Using Parainfluenza Virus
    Michael Cho; Fiscal Year: 2004
    ..abstract_text> ..
  3. Development of a vaccine against SARS-CoV
    Michael Cho; Fiscal Year: 2005
    ..abstract_text> ..
  4. HIV-1 vaccine using variable loop-modified envelopes
    Michael Cho; Fiscal Year: 2006
    ..Successful completion of this study will provide new reagents and strategies for eliciting potent humoral immune response, and would represent a major step forward in AIDS vaccine development efforts. ..
  5. A novel approach of generating combinatorial libraries
    Michael Cho; Fiscal Year: 2006
    ..abstract_text> ..